ArticleOrthopaedic surgery2026
Development and Validation of Daping Orthopedics Operative Risk Scoring System for Geriatric Hip Fracture (DOORS-GHF) for Predicting Postoperative Outcomes in Geriatric Hip Fracture Patients: A Multicenter Retrospective Comparative Study.
Article in Orthopaedic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveWith China's accelerating population aging, geriatric hip fractures pose a growing clinical challenge. High comorbidity burden and diminished physiological reserve drive elevated postoperative complication and mortality risks in this population. However, most existing systems were developed decades ago, incompatible with modern perioperative advances, and are not tailored for geriatric hip fracture patients, resulting in unsatisfactory predictive specificity. To fill this gap, we developed the Daping Orthopedics Operative Risk Scoring System for Geriatric Hip Fracture (DOORS-GHF) and evaluated its predictive accuracy and clinical utility.
methodsWe collected 4417 geriatric patients with hip fractures who underwent operative treatment at multicenter hospitals between 2012 and 2025. A total of 1599 patients were finally enrolled in this study. Of these, 1199 cases were included for the development of the scoring system. Using binary logistic regression with preoperative physiological score (PS) and operative severity score (OS) as independent variables, we constructed the DOORS-GHF model to predict 30-day postoperative complications and mortality. The remaining 400 cases formed the external validation cohort, in which we compared DOORS-GHF against the Daping Orthopedic Operative Risk Scoring System for Senile Patient version 3.0 (DORSSSP v3.0) and the Portsmouth Physiological and Operative Severity Score for the Enumeration of Mortality and Morbidity (P-POSSUM) using AUC, sensitivity, specificity, Hosmer-Lemeshow calibration, Brier score, and decision curve analysis (DCA).
resultsThe DOORS-GHF predictive equations were ln[R/(1 - R)] = -5.089 - 0.114 × OS + 0.226 × PS (complications) and ln[Z/(1 - Z)] = -10.308 + 0.655 × OS + 0.201 × PS (mortality). In the validation cohort (n = 400), 30-day mortality was 2.0% (8/400) and complication rate was 6.5% (26/400). DOORS-GHF outperformed both comparators across all metrics. For complication prediction, it achieved the highest AUC (0.878), acceptable calibration (HL χ
conclusionsDOORS-GHF demonstrated superior discrimination, calibration, accuracy, and clinical utility over DORSSSP v3.0 and P-POSSUM in geriatric hip fracture patients. As a precise and practical system for assessing the risk of 30-day postoperative complications and mortality, it holds strong potential to improve perioperative decision-making and patient counseling in this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.